Search results
Results From The WOW.Com Content Network
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
But 23andMe’s core business featured a fundamental flaw: Once people had their genomic data, they didn’t need to perform the test—or pay 23andMe—again. Another problem popped up in 2013 ...
With a $999 price-tag, it’s leaps and bounds more expensive than the next highest-priced tier you can buy. The service starts at $999 for a full year, and renews at $499. The service starts at ...
The 23andMe data leak was a data breach at personal genomics company 23andMe reported in October 2023. The cyberattack gathered profile and ethnicity information from millions of users. The affected customers were reported as primarily Ashkenazi Jews but also including hundreds of thousands of ethnically Chinese users. [ 1 ]
If you are planning on buying a home in the next five years, a few experts suggest you stay away from New Jersey and six other states. GoBankingRates, a personal finance site, asked a couple ...
Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her leadership style. “What will be most interesting is writing the story in ...
Monmouth's inventory in May was down 27% from a year ago, while Ocean's inventory was down 29% during that time. By comparison, New Jersey had 2% more inventory than a year ago, Otteau said.
23andMe continued to evolve its services, and in 2015, the FDA granted authorization to market its screening for Bloom syndrome, a rare genetic disorder, the company said at the time.